Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 156

Cited In for PubMed (Select 22975340)

1.

Hybrid flagellin as a T cell independent vaccine scaffold.

Bennett KM, Gorham RD Jr, Gusti V, Trinh L, Morikis D, Lo DD.

BMC Biotechnol. 2015 Aug 12;15:71. doi: 10.1186/s12896-015-0194-0.

2.

Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy.

Flingai S, Plummer EM, Patel A, Shresta S, Mendoza JM, Broderick KE, Sardesai NY, Muthumani K, Weiner DB.

Sci Rep. 2015 Jul 29;5:12616. doi: 10.1038/srep12616.

3.

Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes.

Poggianella M, Slon Campos JL, Chan KR, Tan HC, Bestagno M, Ooi EE, Burrone OR.

PLoS Negl Trop Dis. 2015 Jul 28;9(7):e0003947. doi: 10.1371/journal.pntd.0003947. eCollection 2015 Jul.

4.

Wolbachia Reduces the Transmission Potential of Dengue-Infected Aedes aegypti.

Ye YH, Carrasco AM, Frentiu FD, Chenoweth SF, Beebe NW, van den Hurk AF, Simmons CP, O'Neill SL, McGraw EA.

PLoS Negl Trop Dis. 2015 Jun 26;9(6):e0003894. doi: 10.1371/journal.pntd.0003894. eCollection 2015 Jun.

5.

The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response.

Flipse J, Smit JM.

PLoS Negl Trop Dis. 2015 Jun 11;9(6):e0003749. doi: 10.1371/journal.pntd.0003749. eCollection 2015 Jun. Review.

6.

Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia.

Dorigatti I, Aguas R, Donnelly CA, Guy B, Coudeville L, Jackson N, Saville M, Ferguson NM.

Vaccine. 2015 Jul 17;33(31):3746-51. doi: 10.1016/j.vaccine.2015.05.059. Epub 2015 Jun 4.

7.

Dengue fever in China: an emerging problem demands attention.

Jin X, Lee M, Shu J.

Emerg Microbes Infect. 2015 Jan;4(1):e3. doi: 10.1038/emi.2015.3. Epub 2015 Jan 7. No abstract available.

8.

Discovery of dengue virus NS4B inhibitors.

Wang QY, Dong H, Zou B, Karuna R, Wan KF, Zou J, Susila A, Yip A, Shan C, Yeo KL, Xu H, Ding M, Chan WL, Gu F, Seah PG, Liu W, Lakshminarayana SB, Kang C, Lescar J, Blasco F, Smith PW, Shi PY.

J Virol. 2015 May 27. pii: JVI.00855-15. [Epub ahead of print]

PMID:
26018165
9.

Prospective Cohort Study with Active Surveillance for Fever in Four Dengue Endemic Countries in Latin America.

Dayan G, Arredondo JL, Carrasquilla G, Deseda CC, Dietze R, Luz K, Costa MS, Cunha RV, Rey LC, Morales J, Reynales H, Miranda M, Zambrano B, Rivas E, Garbes P, Noriega F.

Am J Trop Med Hyg. 2015 Jul 8;93(1):18-23. doi: 10.4269/ajtmh.13-0663. Epub 2015 May 26.

10.

Dengue: Moving from Current Standard of Care to State-of-the-Art Treatment.

Gan VC.

Curr Treat Options Infect Dis. 2014;6(3):208-226. Review.

11.

The dengue vaccine pipeline: Implications for the future of dengue control.

Schwartz LM, Halloran ME, Durbin AP, Longini IM Jr.

Vaccine. 2015 Jun 26;33(29):3293-8. doi: 10.1016/j.vaccine.2015.05.010. Epub 2015 May 16. Review.

13.

Cellular promyelocytic leukemia protein is an important dengue virus restriction factor.

Giovannoni F, Damonte EB, García CC.

PLoS One. 2015 May 11;10(5):e0125690. doi: 10.1371/journal.pone.0125690. eCollection 2015.

14.

A critical assessment of vector control for dengue prevention.

Achee NL, Gould F, Perkins TA, Reiner RC Jr, Morrison AC, Ritchie SA, Gubler DJ, Teyssou R, Scott TW.

PLoS Negl Trop Dis. 2015 May 7;9(5):e0003655. doi: 10.1371/journal.pntd.0003655. eCollection 2015 May. Review.

15.

Reviewing dengue: still a neglected tropical disease?

Horstick O, Tozan Y, Wilder-Smith A.

PLoS Negl Trop Dis. 2015 Apr 30;9(4):e0003632. doi: 10.1371/journal.pntd.0003632. eCollection 2015 Apr. Review.

16.

A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture.

Raut R, Beesetti H, Tyagi P, Khanna I, Jain SK, Jeankumar VU, Yogeeswari P, Sriram D, Swaminathan S.

Virol J. 2015 Feb 8;12:16. doi: 10.1186/s12985-015-0248-x.

17.

Estimating dengue transmission intensity from sero-prevalence surveys in multiple countries.

Imai N, Dorigatti I, Cauchemez S, Ferguson NM.

PLoS Negl Trop Dis. 2015 Apr 16;9(4):e0003719. doi: 10.1371/journal.pntd.0003719. eCollection 2015 Apr.

18.

New challenges in modern vaccinology.

Centlivre M, Combadière B.

BMC Immunol. 2015 Mar 26;16:18. doi: 10.1186/s12865-015-0075-2.

19.

Machine learning methods enable predictive modeling of antibody feature:function relationships in RV144 vaccinees.

Choi I, Chung AW, Suscovich TJ, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, O'Connell RJ, Francis D, Robb ML, Michael NL, Kim JH, Alter G, Ackerman ME, Bailey-Kellogg C.

PLoS Comput Biol. 2015 Apr 13;11(4):e1004185. doi: 10.1371/journal.pcbi.1004185. eCollection 2015 Apr.

20.

CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice.

Zellweger RM, Tang WW, Eddy WE, King K, Sanchez MC, Shresta S.

J Virol. 2015 Jun;89(12):6494-505. doi: 10.1128/JVI.00036-15. Epub 2015 Apr 8.

PMID:
25855749
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk